Trial Profile
Long-term clinical outcomes after sirolimus-eluting stent implantation
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 21 Oct 2015
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Adverse reactions; Therapeutic Use
- 21 Oct 2015 New trial record
- 02 Sep 2015 Results presented at ESC Congress 2015: Annual Congress of the European Society of Cardiology.
- 02 Sep 2015 Stents were implanted between April 2004 and December 2006, and the median follow-up period was 8.2 years, according to the ESC 2015 abstract